PDS BIOTECHNOLOGY CORP
PDSBNASDAQ🏆 #3664 by market capEarnings Aug 11US Equity
$0.26▼ $0.17 (−64.87%)
🌙 After hours$0.27▲ 6.19%Regular close · extended-hours price shown1h—
24h▼ 64.9%
7d▼ 64.0%
14d▼ 61.9%
30d▼ 65.3%
1y▼ 79.0%
🏦Market Cap
$14M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
54
Weak
📊
Analyst Ratings
Price
$0.2568
Total
7
Raised
0
Lowered
1
Avg PT
$9.00
H / L
$9 / $9
| Institution | Action | Rating | Date |
|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-04-15 |
B. Riley Securities | Reiterated | Buy | 2025-11-25 |
Alliance Global Partners | Reiterated | Buy | 2024-08-20 |
Oppenheimer | Reiterated | Outperform | 2023-11-15 |
Chardan Capital | Reiterated | Buy | 2022-11-15 |
Cantor Fitzgerald | Reiterated | Overweight | 2021-06-28 |
H.C. Wainwright | Downgraded | Buy → Neutral | 2020-03-30 |
One row per institution, most recent rating